Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties

Medicine & Life Sciences

• human MMP2 protein 100%
• Matrix Metalloproteinase 2 62%
• Fibroblasts 42%
• progelatinase 35%
• prostromelysin 30%
• Matrix Metalloproteinases 27%
• Collagen Type V 25%
• 4-aminophenylmercuriacetate 21%
• Collagen Type IV 20%
• Enzyme Precursors 14%
• Matrix Metalloproteinase 3 14%
• Matrix Metalloproteinase 1 13%
• Azocoll 10%
• procollagenase 9%
• Thermolysin 8%
• Plasma Kallikrein 8%
• Cathepsin G 8%
• 1,10-phenanthroline 8%
• Aspartic Acid Proteases 8%
• trypsin drug combination chymotrypsin 8%
• Autolysis 7%
• Endopeptidases 7%
• Gelatinases 7%
• Tissue Inhibitor of Metalloproteinases 7%
• Leukocyte Elastase 7%
• Cysteine Proteases 6%
• Fibrinolysin 6%
• Elastin 6%
• Serine Proteases 6%
• Proteoglycans 6%
• Laminin 6%
• Gelatin 6%
• Metalloproteases 6%
• Edetic Acid 5%
• Conditioned Culture Medium 5%
• Thrombin 5%
• Fibronectins 5%
• Polyacrylamide Gel Electrophoresis 5%
• Digestion 5%

Chemical Compounds

• Collagen 53%
• Purification 38%
• Acetate 15%
• Elastin 14%
• Proteoglycan 14%
• Fibronectin 13%
• Thrombin 12%
• Gelatin 11%
• 1,10-phenanthroline 10%
• Trypsin 10%
• Serine 10%
• Cysteine 9%
• Macromolecule 9%
• pH Value 9%
• Plasma 6%